Björklund Pharma is an early-stage biopharmaceutical company with product candidates within the following therapeutic areas:

• Psychiatry
• Neurology
• Pain
• Sleep
• Ophthalmology
• Cardiology
• Pulmonology/Respiratory
• Gastrointestinal
• Renal/Hepatic
• Hematology (Blood Disorders)
• Endocrinology (Hormonal Disorders)
• Dermatology
• Bone Metabolism/Rheumatology
• Allergy and Immunology
• Infectious Diseases
• Pediatrics
• Women’s Health
• Geriatrics (Elderly Care)
• Toxicology
• Nutraceuticals
• Sports Supplements and Rehabilitation Medicine

Most of the company’s product candidates are in the design, development, or early preclinical stages. Various tests and experiments are conducted during these phases to determine safety, effectiveness, and body metabolism. This information is used to design and plan clinical trials involving human subjects.